Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Advanced Medicine

Manufacture Small Molecules

Games, Drugs, and Rock ‘n’ Roll

| Stephanie Sutton

How pharmaceutical therapeutics are expanding into a whole new galaxy of options.

Business & Regulation Advanced Medicine

mRNA + Cell and Gene = ???

| Angus Stewart

We want to hear your thoughts on what mRNA could do for cell and gene therapy

Business & Regulation Business Practice

Time Will Always Tell

| Maryam Mahdi

Sitting Down With Dolores Schendel, Chief Executive Officer and Chief Scientific Officer at Medigene.

Manufacture Advanced Medicine

Looking Inwards: Solving Gene Therapy Challenges Using the Human Commensal Virome

| Tuyen Ong

Can we harness the commensal virome to help overcome bumps in the gene therapy development curve?

Business & Regulation Profession

Thursday is the Deadline

Nominations and voting for the Power List, Company of the Year Awards, and Innovation Awards ends on Thursday 17 March

Business & Regulation Advanced Medicine

The Champions of Cell & Gene Therapy

In this new series, we ask industry leaders in the cell and gene field to answer key questions about the industry.

Discovery & Development Drug Discovery

The Cell Reprogrammer

We sit down to interview Louise Modis, Chief Scientific Officer at Mogrify, UK, about her career and role at the company.

Manufacture Advanced Medicine

SaudiVax: Regionalizing and Democratizing Cell & Gene Therapy

| Sponsored by MilliporeSigma

How SaudiVax is partnering to help patients in the Middle East and Africa to access advanced medicine.

Business & Regulation Advanced Medicine

Gearing Up for the 2022 Power List and More

2022 is well underway, and with it comes The Medicine Maker Company of the Year Awards. Our old faithful Power List is back too.

Manufacture Advanced Medicine

A Not So Rare Problem

| Timothy J. Miller, Erandi De Silva

Gene therapy can help millions of patients with rare diseases, but one hurdle is preventing the field from achieving liftoff.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register